BRAF and non-small cell lung carcinoma: In NSCLC, BRAF Classes II and III are present in 65% of the BRAF-positive patients (Fig. 1b), with distinct frequencies among different mutations within each class (Supplementary Fig. 1c, 1d and 1e).